Nabota® (Jeuveau®) Botulinum Toxin Type A [South Korea]

Nabota® (Jeuveau®) – Botulinum Toxin Type A | Premium Purity from South Korea

Product Overview

Nabota®, also known as Jeuveau® in the United States, is a highly purified Botulinum Toxin Type A developed and manufactured by Daewoong Pharmaceutical Co., Ltd. — one of South Korea’s leading pharmaceutical manufacturers. Known for its ≥99% purity, rapid onset of action, and consistent clinical-grade formulation, Nabota® is widely used in research focused on neuromuscular inhibition, facial muscle dynamics, and anti-aging mechanisms. While Jeuveau® is approved by the U.S. FDA for therapeutic use, this version of Nabota® is distributed strictly for research use only (RUO).

Key Features & Advantages

• ✅ Made in South Korea by Daewoong Pharmaceutical
  Produced under GMP-certified facilities with strict quality control.

• ✅ Ultra-High Purity (≥99%)
  Extremely low bacterial protein load helps reduce immunogenic risk.

• ✅ Fast Onset and Long Duration
  Effective within 2–3 days; duration of effect up to 12–16 weeks.

• ✅ Controlled Diffusion
  Suitable for precise localized neuromuscular studies.

• ✅ Cost-Effective for Labs and Clinics
  A high-performance alternative to Botox® or Dysport® in research models.

Product Specifications

• Product Name: Nabota® (Jeuveau®) Botulinum Toxin Type A

• Active Ingredient: Clostridium botulinum toxin type A

• Form: Lyophilized powder

• Package Size: 100 Units / vial

• Appearance: White to off-white powder; clear, colorless solution after reconstitution

• Origin: South Korea

• Manufacturer: Daewoong Pharmaceutical Co., Ltd.

• Storage: Store refrigerated at 2°C–8°C; use within 24 hours after reconstitution

• Intended Use: Research Use Only (RUO) – Not for human or veterinary use

How It Works – Mechanism of Action

Nabota® (Jeuveau®) blocks the release of acetylcholine at neuromuscular junctions, preventing muscle contraction. Once inside the neuron, the toxin cleaves the SNAP-25 protein, disabling the release mechanism of acetylcholine, resulting in temporary muscle paralysis. This action is particularly useful for studying motor inhibition, wrinkle formation mechanisms, and therapeutic modeling in experimental setups.

For scientific references on Botulinum Toxin A’s pharmacodynamics, see related PubMed publications.

Applications in Research

• Facial muscle inhibition and wrinkle simulation

• Anti-aging compound testing

• Neuromuscular junction signal pathway modeling

• Botulinum toxin comparative studies

• Hyperhidrosis or spasticity modeling

Compliance Statement

This product is manufactured in South Korea by Daewoong Pharmaceutical Co., Ltd. and is officially exported for research and laboratory use only. It is not intended for diagnostic, therapeutic, or cosmetic use in humans or animals. All researchers and institutional buyers must ensure they comply with applicable local regulations before handling or using botulinum-based compounds.

Tags / Keywords

Botulinum Toxin Type A, Nabota, Jeuveau, Daewoong Toxin, Korean Botulinum, High Purity Toxin, RUO Botulinum, Aesthetic Research Toxin, Anti-aging Toxin, Research Use Only, Neuromodulator Research